Porcilis AR-T

Country: United Kingdom

Language: English

Source: VMD (Veterinary Medicines Directorate)

Active ingredient:

Bordetella bronchiseptica, Pasteurella multocida

Available from:

Intervet UK Ltd

ATC code:

QI09AB04

INN (International Name):

Bordetella bronchiseptica, Pasteurella multocida

Authorization status:

Expired

Summary of Product characteristics

                                                                                                                                                                         Revised 27 May 2010
                                                                                                                                                                                  AN. 
01603/2009
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Porcilis AR-T
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
_Active substance(s)_
Per dose of 2 ml:
- _Pasteurella multocida_ dermonecrotic toxin (as toxoid)
1.80 
g
- Inactivated _Bordetella bronchiseptica_ cells
45 mg
_Adjuvant(s)_
Paraffin
941.44 mg
3.
PHARMACEUTICAL FORM
Emulsion for injection
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Pigs (sows and gilts)
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For vaccination of sows and gilts to reduce infection and clinical signs of atrophic
rhinitis caused by Bordetella bronchiseptica and Pasteurella multocida in their progeny.
Protection has been demonstrated in the progeny of sows and gilts vaccinated during
pregnancy.
4.3
CONTRAINDICATIONS
Do not vaccinate unhealthy animals. 
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None
4.5
SPECIAL PRECAUTIONS FOR USE, INCLUDING SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON
ADMINISTERING THE MEDICINAL PRODUCT TO ANIMALS
Allow vaccine to reach ambient temperature  (between +15 and +25°C) before  use.
Shake vigorously before and during use. Ensure that vaccination equipment is clean and
sterile before u